- 产品描述
- 产品组分
- 文件资源
- 营销中心
- 注意事项
- FAQ
- 文献追踪
-
原位DNA损伤分析试剂盒是一套方便的工具,允许实验人员通过原位测量H2AXSer139的磷酸化来检测DNA损伤或凋亡。 该试剂盒是随时可用的,提供了所有必要的组件,通过使用培养的贴壁细胞通过磷酸H2AXSer139检测来原位特异性地测量DNA损伤。
原位DNA损伤分析试剂盒是一种基于全细胞的DNA损伤和/或凋亡检测试剂盒。 在这个实验中,贴壁细胞在传统的96孔微孔板中培养。 经过你的实验处理,细胞被固定并渗透。 然后用抗磷酸化的H2AXSer139抗体检测H2AX在丝氨酸139处的磷酸化,这是DNA损伤的敏感标记。 磷酸H2AXSer139的比例或数量可以通过HRP偶联的二抗显色系统进行定量,并与显色强度成正比。
合作开发的原位DNA损伤分析试剂盒。这个工具可在一个微孔板中定量组蛋白H3磷酸化(Ser10)修饰类型,具有如下的优势和特性:
- 快速高效的操作流程,3小时内即可完成
- 创新的比色分析,不需要放射性,电泳或色谱
- 在不需要准备细胞裂解液的情况下,即可测量组蛋白H2AX的原位磷酸化
- 微孔板格式使分析适合高通量分析增加或抑制DNA损伤的药物
- 简单,可靠,一致的分析条件
关键词:- 原位DNA损伤分析试剂盒
-
产品组分
组分内容
型号:A-P-6001-96(96次)
型号:A-P-6001-192(192次) 储存温度
A1
10x Wash Buffer
30 ml 2x30 ml 4°C A2 Permeabilizing Buffer 30 ml 2x30 ml 室温 A3 Blocking Buffer
20 ml 2x20 ml 4°C A4 Antibody Buffer 10 ml 20 ml 室温 A5 Capature Antibody,1000ug/ml*
10 ul 20 ul 4°C A6 Detection Antibody,200ug/ml* 20 ul 40 ul –20°C A7 Developing Solution
12 ml 24 ml 4°C A8 Stop Solution
6 ml 12 ml 室温 30% H2O2 Solution 0.5 ml 1 ml 4°C Positive Control(Etoposide,2mM) 10 ul 20 ul –20°C Microplates
1 2 室温 操作手册
1
1
室温
*注意:在使用之前,为了最大限度的利用产品,请在开盖之前离心溶液至管底。在使用之前,将冷冻的试剂瓶约5~10分钟恢复到室温。
-
注意事项
保存建议 推荐蓝冰或冰袋运输。当您收到产品后,按照说明书建议保存各组分。 警告 本品仅供科研使用,请勿用于临床与诊断。 -
FAQ

-
Taj M.B. et. al. (January 2022). Exploring novel fluorine rich fuberidazole derivatives as hypoxic cancer inhibitors: design, synthesis, pharmacokinetics, molecular docking and DFT evaluations bioRxiv.
Zhang Y et al. et. al. (September 2019). N-Acetyl Cysteine as a Novel Polymethyl Methacrylate Resin Component: Protection against Cell Apoptosis and Genotoxicity Oxidative Medicine and Cellular Longevity.
Festuccia C et. al. (February 2018). The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma. J Hematol Oncol. 11(1):32.
RuiXie et. al. (August 2017). Rational design, synthesis and preliminary antitumor activity evaluation of a chlorambucil derivative with potent DNA/HDAC dual-targeting inhibitory activity Bioorganic & Medicinal Chemistry Letters. 27(16)
Gravina GL et. al. (June 2017). The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models. Tumour Biol. 39(6):1010428317695528.
Lou JS et. al. (August 2016). Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling. Sci Rep. 6:31926.
Sarojini S et. al. (July 2015). A combination of high dose rate (10X FFF/2400 MU/min/10 MV X-rays) and total low dose (0.5 Gy) induces a higher rate of apoptosis in melanoma cells in vitro and superior preservation of normal melanocytes. Melanoma Res.
Sleire L et. al. (March 2015). Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc<sup>-</sup>, leading to glutathione depletion. Oncogene.
Błaszczak-Świątkiewicz K et. al. (March 2015). Some characteristics of activity of potential chemotherapeutics--benzimidazole derivatives. Adv Med Sci. 60(1):125-32.
Błaszczak-Świątkiewicz K et. al. (September 2014). Biological Evaluation of the Activity of Some Benzimidazole-4,7-dione Derivatives. Molecules. 19(10):15361-73.
Zhao J et. al. (August 2014). AKR1C3 Overexpression Mediates Methotrexate Resistance in Choriocarcinoma Cells. Int J Med Sci. 11(11):1089-97.
Gravina GL et. al. (June 2014). Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models. Prostate. 74(8):852-68.
Błaszczak-Świątkiewicz K et. al. (February 2014). Biological approach of anticancer activity of new benzimidazole derivatives. Pharmacol Rep. 66(1):100-6.
Błaszczak-Świątkiewicz K et. al. (July 2013). Antiproliferative activity of new benzimidazole derivatives. Acta Biochim Pol. 60(3):427-33.
Takeda S et. al. (March 2013). (-)-Xanthatin up-regulation of the GADD45γ tumor suppressor gene in MDA-MB-231 breast cancer cells: role of topoisomerase IIα inhibition and reactive oxygen species. Toxicology. 305:1-9.
Hoeferlin LA et. al. (September 2011). Activation of p21-Dependent G1/G2 Arrest in the Absence of DNA Damage as an Antiapoptotic Response to Metabolic Stress. Genes Cancer. 2(9):889-99.
Yao JY et. al. (December 2010). TAp63 plays compensatory roles in p53-deficient cancer cells under genotoxic stress. Biochem Biophys Res Commun. 403(3-4):310-5.
猜你喜欢
在线留言
如果您对我们的产品感兴趣,请留下您的信息,我们将尽快与您联系,谢谢!
艾维缔官网
艾德官网
B站IVDSHOW
抖音军哥聊表观
视频号艾维缔
小红书艾维缔
快手表观盒子
表观遗传学
联系我们

